Superiority Of Pegcetacoplan Compared To Eculizumab In Patients With Paroxysmal Nocturnal Hemoglobinuria, Regardless Of Prior Transfusion Requirement: Analysis At 16-Weeks Of PEGASUS Phase 3 Randomized Trial